CN117716031B - 使用dkc1进行rna编辑的组合物、系统和方法 - Google Patents
使用dkc1进行rna编辑的组合物、系统和方法Info
- Publication number
- CN117716031B CN117716031B CN202280037916.7A CN202280037916A CN117716031B CN 117716031 B CN117716031 B CN 117716031B CN 202280037916 A CN202280037916 A CN 202280037916A CN 117716031 B CN117716031 B CN 117716031B
- Authority
- CN
- China
- Prior art keywords
- gsnorna
- dkc1
- protein
- sequence
- rna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/52—Isomerases (5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021096122 | 2021-05-26 | ||
| CNPCT/CN2021/096122 | 2021-05-26 | ||
| PCT/CN2022/095172 WO2022247896A1 (en) | 2021-05-26 | 2022-05-26 | Compositions, systems and methods of rna editing using dkc1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117716031A CN117716031A (zh) | 2024-03-15 |
| CN117716031B true CN117716031B (zh) | 2025-12-05 |
Family
ID=84228426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280037916.7A Active CN117716031B (zh) | 2021-05-26 | 2022-05-26 | 使用dkc1进行rna编辑的组合物、系统和方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240238394A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4347834A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7902855B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN117716031B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022280907A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3219203A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL308565A (cg-RX-API-DMAC10.html) |
| TW (1) | TW202307205A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022247896A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024259332A2 (en) * | 2023-06-16 | 2024-12-19 | The University Of Chicago | Methods and compositions for regulating gene expression |
| TW202504646A (zh) * | 2023-06-16 | 2025-02-01 | 北京大學 | 利用環狀rna抑制無義介導的降解的系統和方法 |
| WO2025119204A1 (en) * | 2023-12-04 | 2025-06-12 | Modit Therapeutics Beijing Limited | Methods and compositions for improved readthrough of pseudouridine-modified codons |
| CN121380197B (zh) * | 2025-12-22 | 2026-04-24 | 北京大学 | 基于假尿苷修饰的rna单碱基编辑系统及方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112020557A (zh) * | 2018-03-27 | 2020-12-01 | 罗切斯特大学 | 用于假尿苷化的核酸分子 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5989911A (en) * | 1997-05-09 | 1999-11-23 | University Of Massachusetts | Site-specific synthesis of pseudouridine in RNA |
| US8603457B2 (en) * | 2005-12-02 | 2013-12-10 | University Of Rochester | Nonsense suppression and genetic codon alteration by targeted modification |
| US20210340197A1 (en) * | 2018-08-31 | 2021-11-04 | The Regents Of The University Of California | Directed pseudouridylation of rna |
-
2022
- 2022-05-25 TW TW111119567A patent/TW202307205A/zh unknown
- 2022-05-26 JP JP2023568295A patent/JP7902855B2/ja active Active
- 2022-05-26 CA CA3219203A patent/CA3219203A1/en active Pending
- 2022-05-26 CN CN202280037916.7A patent/CN117716031B/zh active Active
- 2022-05-26 IL IL308565A patent/IL308565A/en unknown
- 2022-05-26 US US18/563,822 patent/US20240238394A1/en active Pending
- 2022-05-26 WO PCT/CN2022/095172 patent/WO2022247896A1/en not_active Ceased
- 2022-05-26 AU AU2022280907A patent/AU2022280907A1/en not_active Abandoned
- 2022-05-26 EP EP22810620.9A patent/EP4347834A4/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112020557A (zh) * | 2018-03-27 | 2020-12-01 | 罗切斯特大学 | 用于假尿苷化的核酸分子 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022280907A1 (en) | 2023-11-16 |
| WO2022247896A1 (en) | 2022-12-01 |
| TW202307205A (zh) | 2023-02-16 |
| JP7902855B2 (ja) | 2026-08-10 |
| US20240238394A1 (en) | 2024-07-18 |
| CN117716031A (zh) | 2024-03-15 |
| IL308565A (en) | 2024-01-01 |
| CA3219203A1 (en) | 2022-12-01 |
| JP2024519733A (ja) | 2024-05-21 |
| EP4347834A4 (en) | 2025-05-21 |
| EP4347834A1 (en) | 2024-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12037602B2 (en) | Methods and compositions for modulating a genome | |
| US20240417757A1 (en) | Methods and compositions for modulating a genome | |
| US20230242899A1 (en) | Methods and compositions for modulating a genome | |
| US12031162B2 (en) | Methods and compositions for modulating a genome | |
| WO2022247896A1 (en) | Compositions, systems and methods of rna editing using dkc1 | |
| WO2023039440A9 (en) | Hbb-modulating compositions and methods | |
| US20230053353A1 (en) | Targeting transfer rna for the suppression of nonsense mutations in messenger rna | |
| US20240374759A1 (en) | Methods and compositions for modulating a genome | |
| CN112020557A (zh) | 用于假尿苷化的核酸分子 | |
| US20230348939A1 (en) | Methods and compositions for modulating a genome | |
| WO2024073385A2 (en) | Synthetic polypeptides and uses thereof | |
| WO2024137767A1 (en) | Compositions and methods for modifying dux4 | |
| WO2025119204A1 (en) | Methods and compositions for improved readthrough of pseudouridine-modified codons | |
| IL323067A (en) | Compositions and methods of serpina modulators | |
| WO2025265017A1 (en) | Ass1 gene insertion for the treatment of citrullinemia type i | |
| WO2025193808A1 (en) | Cns-specific gene replacement therapy for genetic forms of als/ftd |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information | ||
| CB02 | Change of applicant information |
Country or region after: China Address after: Room 101, Building B, Innovation Building, No. 29 Shengshengyuan Road, Changping District, Beijing 102206, Beijing Dart International Innovation Platform K115 Applicant after: Ruiyu (Beijing) Biopharmaceutical Technology Co.,Ltd. Address before: 101, Building B, Innovation Building, No. 29 Shengshengyuan Road, Changping District, Beijing, 102200. Beijing Dart International Innovation Platform K115 Applicant before: Ruiyu (Beijing) Biopharmaceutical Co.,Ltd. Country or region before: China |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |